Invitae Arrhythmia Comprehensive Panel
Use
The Invitae Arrhythmia Comprehensive Panel provides comprehensive genetic testing for inherited arrhythmia conditions. This test analyzes up to 80 genes associated with arrhythmias, including certain syndromic conditions where arrhythmia is a feature. Genetic testing can help establish or confirm the diagnosis, clarify risks, and inform management for individuals with clinical symptoms of inherited arrhythmia, as well as asymptomatic individuals with a family history of associated pathogenic variants.
Special Instructions
Testing is New York approved. Request a specimen collection kit if needed. Ensure adherence to guidelines for sample collection and handling to avoid potential test inaccuracies. Contact client services for any specific queries about sequences outside the test scope.
Limitations
This test covers coding exons and adjacent intronic regions of each gene, but excludes promoter regions, some non-coding regions, and certain complex structural variants. Sequence changes outside specified regions are not covered. Some types of structural rearrangements and variants with complex architectures may not be detectable, and in rare cases, single-exon copy number changes may not be analyzed due to technical limitations.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
10-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3mL
Minimum Volume
Not provided
Container
purple-top EDTA tube (K2EDTA or K3EDTA)